Thursday the 29th of January Nansen Neuroscience Network organized a meeting about multiple sclerosis at Vika Atrium in Oslo. Around 50 participants from academia and industry were gathered to hear about personalized MS treatment and biomarkers. 

Hvordan sikre mer innovasjon og ny behandling ut fra verdensledende nevroforskning?

"The Board of Directors of Nansen Neuroscience Network (NNN) have appointed Bjarte Reve as our new CEO. He's one of the few in Norway that previously has been in a similar position and created impressive results, as CEO of Oslo Cancer Cluster NCE. 

December 10th was a spectacular day for Norwegian neuroscience as professors Edvard Moser and May-Britt Moser received their Nobel Medal and Diploma in Stockholm. In connection with the Nobel Prize Award Ceremony, NNN's CEO Leif Rune Skymoen made several appearances in media to comment the prize and share insights on Norwegian neuroscience. 

Tomorrow is an important day for Norwegian neuroscience - the Nobel Laureates in Medicine, Professors Edvard Moser and May-Britt Moser, take centre stage in Stockholm, when they receive the Nobel Medal and Nobel Diploma handed by King Carl XVI Gustaf of Sweden.

Leif Rune Skymoen will from 2015 be the CEO of the company that has bought the Takeda Nycomed production plant in Elverum, Norway.

On the 14th of November, NNN organized a meeting about Magnetic Resonance Imaging (MRI) in multiple sclerosis together with Forskningsenheten for Nevrofag at Domus Medica in Oslo.

PhD candidates from four different Norwegian universities met in Oslo 5-6 November for the first National innovation workshop for PhD candidates in neuroscience. The event was jointly organized by NNN and the Norwegian Research School in Neuroscience (NRSN). 

Pages